BlackRock Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $796K | Hold |
260,927
| – | – | ﹤0.01% | 1913 |
|
|
2016
Q3 | $710K | Buy |
260,927
+2,058
| +0.8% | +$5.6K | ﹤0.01% | 1940 |
|
|
2016
Q2 | $740K | Sell |
258,869
-8,167
| -3% | -$23.3K | ﹤0.01% | 1870 |
|
|
2016
Q1 | $806K | Sell |
267,036
-3,526
| -1% | -$10.6K | ﹤0.01% | 1803 |
|
|
2015
Q4 | $939K | Sell |
270,562
-3,591
| -1% | -$12.5K | ﹤0.01% | 1718 |
|
|
2015
Q3 | $1.04M | Sell |
274,153
-8,950
| -3% | -$33.8K | ﹤0.01% | 1643 |
|
|
2015
Q2 | $1.61M | Sell |
283,103
-656
| -0.2% | -$3.74K | ﹤0.01% | 1340 |
|
|
2015
Q1 | $1.65M | Sell |
283,759
-2,719
| -0.9% | -$15.8K | ﹤0.01% | 1278 |
|
|
2014
Q4 | $1.62M | Buy |
286,478
+63,157
| +28% | +$358K | ﹤0.01% | 1248 |
|
|
2014
Q3 | $913K | Buy |
223,321
+1,222
| +0.6% | +$5K | ﹤0.01% | 1453 |
|
|
2014
Q2 | $1.01M | Sell |
222,099
-48,130
| -18% | -$219K | ﹤0.01% | 1451 |
|
|
2014
Q1 | $1.28M | Buy |
270,229
+1,053
| +0.4% | +$4.99K | ﹤0.01% | 1361 |
|
|
2013
Q4 | $1.27M | Sell |
269,176
-83,970
| -24% | -$395K | ﹤0.01% | 1348 |
|
|
2013
Q3 | $1.41M | Buy |
353,146
+1,308
| +0.4% | +$5.22K | ﹤0.01% | 1257 |
|
|
2013
Q2 | $1.25M | Buy |
+351,838
| New | +$1.25M | ﹤0.01% | 1278 |
|